MondayJul 25, 2022 2:28 pm

QualityStocksNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Committed to Becoming Prominent International Player in Lidar Space

Cepton (NASDAQ: CPTN) recently opened a newly renovated office in Metro Detroit (Troy, Michigan). The office is intended to enable the company to continue to forge close relationships with automakers centered around the heart of the U.S. auto industry. “Having a strong presence in Detroit not only enables us to keep up with the latest trend in the industry but also makes us part of that trend – we are here to demonstrate how lidar is essential to the future of mobility, with our product experts driving informative communications and our application engineers working in the field,” a recent article…

Continue Reading

MondayJul 25, 2022 1:34 pm

QualityStocksNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Leveraging Sapientus Division to Expand into Big Data Services

FingerMotion (NASDAQ: FNGR) is building a deeper channel for revenue in its services for China’s mobile phone users and big data clients. “FingerMotion’s central competencies are in mobile payment and mobile recharge platform solutions, but the company has been expanding into big data services through its Sapientus division. The data services have primarily been marketed as a tool for reinsurance companies as they look for effective measures of risk scoring and ways to simplify policy underwiring purchasing, but FingerMotion has acknowledged it could expand into other industries in the future,” a recent article reads. FingerMotion CEO Martin Shen is quoted…

Continue Reading

MondayJul 25, 2022 1:23 pm

QualityStocksNewsBreaks – Why Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA) Is ‘One to Watch’

Hillcrest (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA), a Vancouver, British Columbia-based company, is engaged in developing high-performance power conversion technologies and digital control systems for next-generation powertrains and grid-connected renewable energy systems. “Hillcrest power inverter technology helps produce efficiencies in electrification and maximize the performance of electric systems, including electric vehicles (“EVs”), motors and generators. The company offers a flexible, single-inverter architecture that can be applied at nearly every stage of the electrification ecosystem, from renewable energy generation through the charging and operation of an EV, to provide full-cycle efficiency and performance improvements,” a recent article reads. “Hillcrest’s first application…

Continue Reading

MondayJul 25, 2022 12:42 pm

QualityStocksNewsBreaks – DPCM Capital Inc.’s (NYSE: XPOA) Pending SPAC Merger Target D-Wave Forms Alliance with Mastercard (NYSE: MA) to Champion Quantum Computing Solutions

DPCM Capital (NYSE: XPOA) recently entered into a definitive transaction agreement with D-Wave Systems Inc., whereby, upon closing of the transaction, shares of the pending parent company – D-Wave Quantum Inc. – are expected to trade on the NYSE under ticker symbol QBTS. D-Wave Systems, a leader in quantum computing systems, software and services, and the only company building both quantum annealing and gate-based quantum computers, and Mastercard (NYSE: MA) recently announced a multi-year strategic alliance to champion the acceleration and adoption of quantum computing solutions. According to the announcement, D-Wave and Mastercard will collaborate on the research and development…

Continue Reading

MondayJul 25, 2022 12:16 pm

QualityStocksNewsBreaks – Correlate Infrastructure Partners Inc. (CIPI) Signs LOI to Acquire Leading Solar, Storage Platform

Correlate Infrastructure Partners (OTCQB: CIPI), a technology-enabled energy optimization and clean-energy solutions provider for North America, has entered into a nonbinding letter of intent (“LOI”) outlining its plans to acquire a top-10 solar, battery storage and roofing provider based in California. According to the announcement, the target company focuses on sales and self-performance construction of solar and roofing services for residential and commercial properties; CIPI anticipates the acquisition to be complete and accretive by the second half of this year, marking the “next evolution” of the company as a community-scale distributed energy company. Highlights of the agreement include expanded national…

Continue Reading

MondayJul 25, 2022 12:04 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Urges Shareholders to Vote in Favor of Proxy Proposals for Upcoming Annual Meeting

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. The company today urged shareholders to vote in favor of the proposals outlined in its definitive proxy statement for the upcoming annual shareholder meeting to be held Wednesday, July 27, 2022. Proposals include the authorization to increase the number of shares available for issuance by the company and the authorization for the board of directors to effect a reverse stock split of the outstanding shares of the company’s common stock, at a split…

Continue Reading

MondayJul 25, 2022 11:52 am

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Issues Update on Phase 2 EB Trial

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today provided an update on its phase 2 clinical trial using investigational drug INM-755 cannabinol (“CBN”) cream for the treatment of patients with epidermolysis bullosa (“EB”). Based on safety data of the first five adult patients who completed the phase 2 study, an independent data monitoring committee agreed it is safe to allow the enrollment of adolescent patients, defined as persons aged twelve to seventeen with EB. “We are pleased that the initial safety data from InMed’s phase 2 EB clinical trial has allowed…

Continue Reading

MondayJul 25, 2022 11:22 am

QualityStocksNewsBreaks – Friendable Inc. (FDBL) Launches Revamped ‘Song of the Summer’ Contest

Friendable (OTC: FDBL), a mobile technology and marketing company, today announced its “Song of the Summer” contest and artist promotion. According to the update, the submission process opened to artists last week as the company received an immediate positive response with entries pouring in. The contest registration will remain open until July 31, 2022, and fan voting will begin in August 2022 to determine each of the five winners per genre. “This contest has been a highly sought after and anticipated promotion since it began with the former Artist Republik management team,” said Friendable CEO Robert A. Rositano Jr. “Now…

Continue Reading

FridayJul 22, 2022 2:13 pm

QualityStocksNewsBreaks – Why QSAM Biosciences Inc. (QSAM) Is ‘One to Watch’

QSAM Biosciences (OTCQB: QSAM), a clinical-stage biotechnology company, is focused on bringing to market targeted therapeutic radiopharmaceuticals. “The company is committed to advancing the fight against cancer through the discovery, development and delivery of effective treatment options for adult and pediatric patients,” a recent article reads. “CycloSam(R), QSAM Biosciences’ initial technology, is a clinical-stage bone targeting radiopharmaceutical invented by world-renowned scientists at IsoTherapeutics Group LLC. … CycloSam is designed to selectively target sites of high bone mineral turnover to deliver a prescribed tumor-killing dose of radiation to the tumor sites while minimizing radiation exposure to nearby healthy tissue. These parameters…

Continue Reading

FridayJul 22, 2022 1:50 pm

QualityStocksNewsBreaks – Silo Pharma Inc. (SILO), UMB Collaborating on Potentially Significant Homing-Peptide Technology

Silo Pharma (OTCQB: SILO) earlier this year extended its research partnership with the University of Maryland, Baltimore (“UMB”) to explore potentially lifesaving joint-homing peptides that target inflamed endothelium (a thin membrane that lines the inside of the heart and blood vessels). “Silo’s partnership with UMB focuses on peptides used for investigating and treating the arthritogenic process or joint disease. Current treatment for arthritis has side effects that include nausea, vomiting, diarrhea, tinnitus, hair loss, seizures, fever, congestion, unusual lumps or masses, and more. OTC arthritis therapeutics, such as common NSAIDs, can produce stomach ulcers, dizziness and indigestion and can have…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered